Amgen Reports Q3 Earnings Beat with $10.4 Billion in Revenue
Amgen (NASDAQ: AMGN) reported third-quarter financial results that exceeded analyst expectations on both the top and bottom lines. The company posted a non-GAAP earnings per share (EPS) of $6.45, surpassing estimates by $0.67, while total revenue reached $10.4 billion, representing an 8.3% increase year-over-year and beating projections by $340 million. Looking ahead to long-term growth, Amgen provided financial guidance for the full year 2026, projecting total revenues to fall within a range of $38.9 billion to $39.7 billion. The strong quarterly performance underscores steady revenue growth and operational efficiency.
Tickers: $AMGN